NET Symposium

Q: 03:00 - 03:20 pm - General Presentation of RHU OPERANDI

Pr. Valérie Vilgrain Department of Radiology, Beaujon Hospital (AP-HP)

Q: 03:20 - 04:00 pm - Epigenetics of Pancreatic NEuroendocrine Tumor (Pan-NET) (30’) & Discussion (10’)

Dr. Ilaria Marinoni Institute of Pathology, University of Bern, Switzerland

Q: 04:00 - 04:30 pm - Features of neuroendocrine tumor patients with long term survival (20’) & Discussion (10’)

Pr. Marianne Pavel Department of Medicine 1, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany

Q: 04:30 - 05:00 pm - Predictive role of Peptide Receptor Radionuclide Therapy (PRRT) (20') & Discussion (10’)

Dr. Aurélie Bando-Delaunay Department of Nuclear Medicine , Beaujon Hospital (AP-HP)

Q: 05:00 - 05:30 pm - Targeted alpha therapy of endocrine neoplasias : relevance and state of clinical advancements (20') & Discussion (10')

Dr. Alexandre Lugat Department of Nuclear Medicine, University Hospital of Nantes

Q: 05:30 - 05:40 pm - Closing remarks

Dr. Louis de Mestier Department of Gastroenterology and Pancreatology, Beaujon Hospital (AP-HP)

Save the date! Monday, June 19, 2023, from 03 pm to 05:40 pm
In-person webinar at Beaujon Hospital (AP-HP) & Online

Speakers & moderators

Topics

Programme

Registration

Access

Downloads

Speakers & moderators

Speakers

Moderators

Topics

General Presentation of RHU^* OPERANDI^*

Epigenetics of Pancreatic NEuroendocrine Tumor (Pan-NET)

Features of neuroendocrine tumor patients with long term survival

Predictive role of Peptide Receptor Radionuclide Therapy (PRRT)

Targeted alpha therapy of endocrine neoplasias : relevance and state of clinical advancements

^*RHU
University-Hospital Research project

^*OPERANDI
Optimisation and imProved Efficacy of targeted RAdioNuclide therapy in Digestive cancers by Imagomics

Programme

02:30 - 03:00 pm

Opening & Welcome Coffee

03:00 - 03:20 pm - General Presentation of RHU OPERANDI

Pr. Valérie Vilgrain
Department of Radiology, Beaujon Hospital (AP-HP)

03:20 - 05:30 pm

Topics & Speakers

03:20 - 04:00 pm - Epigenetics of Pancreatic NEuroendocrine Tumor (Pan-NET) (30’) & Discussion (10’)

Dr. Ilaria Marinoni
Institute of Pathology, University of Bern, Switzerland

04:00 - 04:30 pm - Features of neuroendocrine tumor patients with long term survival (20’) & Discussion (10’)

Pr. Marianne Pavel
Department of Medicine 1, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany

04:30 - 05:00 pm - Predictive role of Peptide Receptor Radionuclide Therapy (PRRT) (20') & Discussion (10’)

Dr. Aurélie Bando-Delaunay
Department of Nuclear Medicine, Beaujon Hospital (AP-HP)

05:00 - 05:30 pm - Targeted alpha therapy of endocrine neoplasias : relevance and state of clinical advancements (20') & Discussion (10')

Dr. Alexandre Lugat
Department of Nuclear Medicine, University Hospital of Nantes

05:30 - 05:40 pm - Closing remarks

Dr. Louis de Mestier
Department of Gastroenterology and Pancreatology, Beaujon Hospital (AP-HP)

05:40 pm

Closing

Registration

Access

Pierre Abrami Auditorium, "Secteur Jaune", Porte 3
Beaujon Hospital
100 boulevard du Général Leclerc
92110 Clichy, France
👉 Coming to Beaujon Hospital (AP-HP)

NET SYMPOSIUM